Condition: Atrial Fibrillation · Sponsor: French Cardiology Society
Pulsed Field Ablation (PFA) represents a recent advance in the treatment of atrial fibrillation (AF), with a safety profile potentially superior to traditional thermal techniques, such as radiofrequency or cryoablation. Its mechanism of action allows tissue selectivity which in theory limits damage to extracardiac structures. However, several cases of right diaphragmatic paralysis have been reported in the literature after PFA, particularly during applications on the right pulmonary veins, near the right phrenic nerve. The available data are from studies without specific diaphragmatic monitoring. The diagnosis of diaphragmatic paralysis is most often based on chest X-ray, a static examination of limited sensitivity, especially for the detection of incomplete paralysis. To date, no prospective multicentre study has evaluated the incidence of diaphragmatic paralysis after PFA with systematic dynamic imaging, such as fluoroscopy, considered the gold standard for the diagnosis of unilateral paralysis.
This description comes directly from the study's public registry record.
Tessa BERGOT, MSc · +33144907033 · tessa.bergot@sfcardio.fr
Always discuss trial participation with your own doctor first.
| Montreal Heart Institute | Montreal, Canada | Not Yet Recruiting |
| CHRU de Tours - Hôpital Trousseau | Chambray-lès-Tours, France | Not Yet Recruiting |
| CHU de Lyon - Hôpital Croix-Rousse | Lyon, France | Not Yet Recruiting |
| Centre Hospitalier de Pau - Hôpital François Mitterrand | Pau, France | Recruiting |
| CHU de Bordeaux - Hôpital Haut-Lévêque | Pessac, France | Not Yet Recruiting |
| Centre Cardiologique du Nord | Saint-Denis, France | Not Yet Recruiting |
| Institut Cardiovasculaire de Strasbourg - Clinique Rhéna | Strasbourg, France | Not Yet Recruiting |
| Clinique Pasteur | Toulouse, France | Not Yet Recruiting |
| Auckland City Hospital | Auckland, New Zealand | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07462910